Celexa is a medication whose active ingredient is citalopram. It is also known by its generic name, citalopram, and is used to treat depression. Celexa helps to improve mood by increasing the levels of serotonin in the brain.
The pricing structure for Celexa is set between £0.23 and £1.66 for every pills. It’s reflective of the size of the packaging and ingredient concentration (30 or 360 mg).
Celexa contains the active ingredient citalopram hydrobromide. Citalopram is a selective serotonin reuptake inhibitor (SSRI) used to treat depression. It influences neurotransmitters in the brain, which can improve mood and emotional stability.
Celexa is available in tablet form and as an oral solution. Tablets are available in doses of 10 mg, 20 mg, and 40 mg. The oral solution contains 2 mg of citalopram per ml. Each form is designed for oral administration.
Celexa is primarily indicated for the treatment of major depressive disorder (MDD) in adults. It may be prescribed off-label for other conditions such as anxiety disorders, obsessive-compulsive disorder (OCD), and panic disorder.
The typical starting dose for adults is 20 mg per day, which may be increased to a maximum of 40 mg per day. Dose adjustments are based on individual response and tolerability. It is advisable to take the medication at the same time each day, with or without food.
Citalopram works by inhibiting the reuptake of serotonin in the brain, increasing serotonin levels in the synaptic cleft. This contributes to enhanced mood and alleviation of depressive symptoms.
Citalopram is well-absorbed from the gastrointestinal tract, reaching peak plasma concentrations within four hours of ingestion. It has a half-life of approximately 35 hours. Metabolism occurs primarily in the liver, and the medication is excreted via urine and feces.
For elderly patients or those with hepatic impairment, a lower maximum dose of 20 mg per day is recommended due to increased plasma concentrations. Pediatric use is not approved for major depressive disorder. Renal impairment usually does not necessitate dose adjustments.
Concomitant use with monoamine oxidase inhibitors (MAOIs) is contraindicated. Caution should be exercised when combining with other SSRIs, serotonin-norepinephrine reuptake inhibitors (SNRIs), or drugs affecting serotonin levels. Interaction with certain antipsychotic medications may increase the risk of QT prolongation.
Common adverse reactions include nausea, dry mouth, somnolence, insomnia, increased sweating, and sexual dysfunction. Less frequent but serious effects include QT prolongation, hyponatremia, and risk of serotonin syndrome, particularly when used with other serotonergic drugs.
Celexa is contraindicated in patients with known hypersensitivity to citalopram or any inactive ingredients in the formulation. It should not be used in patients taking pimozide, as this combination can lead to serious cardiac complications.
Gradual dose reduction is advisable to minimize withdrawal symptoms, such as dizziness, sensory disturbances, and agitation. Sudden discontinuation should be avoided unless medically necessary. Tapering schedules should be individualized for each patient.
Celexa should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Citalopram is excreted in human breast milk; therefore, caution should be exercised when administered to nursing mothers.
Store Celexa tablets and the oral solution at room temperature, away from moisture and heat. Keep the medication in its original container, tightly closed, and out of reach of children and pets.
Patients prescribed Celexa should be monitored for clinical worsening, suicidality, and unusual behavior changes, especially during the initial treatment period or when doses are adjusted. Periodic assessment of liver function and electrolyte levels is recommended.
Inform patients about the importance of adherence to the prescribed regimen and to report any adverse reactions or suicidal thoughts immediately. Patients should avoid alcohol and inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements.
When prescribed alongside other medications, healthcare providers must evaluate potential drug interactions. Combining Celexa with other CNS depressants or MAOIs requires thorough clinical assessment and monitoring.
Clinical trials have illustrated the efficacy of Celexa in improving symptoms of depression. Response rates typically become evident after two to four weeks of consistent use. Full therapeutic effects may take several weeks longer.
In cases of overdose, symptoms such as dizziness, tremor, somnolence, and convulsions may occur. Immediate medical attention is necessary, and supportive treatment should be provided. Activated charcoal and gastric lavage may be considered within a short timeframe of ingestion.
Adjustments may be necessary for patients with comorbid conditions such as cardiovascular diseases, as Celexa may affect heart rhythm. Monitoring and dosage adjustments are crucial for these patients to minimize potential risks.
Long-term use of Celexa necessitates periodic reassessment of the therapeutic benefits versus potential risks. Patients should undergo regular evaluations to determine the continued appropriateness of the treatment regimen.
Pharmacists should provide educational materials and counseling to support optimal adherence. Strategies may include setting reminders and using pill organizers, especially for patients with memory issues or complex medication regimens.
Generic citalopram is available and may offer a cost-effective alternative to branded Celexa. Pharmacy professionals should discuss generic options with patients, considering their clinical and economic situations.
Starting at a lower dose and gradually increasing can help mitigate initial side effects. Clinicians should provide clear instructions on titration schedules to optimize patient comfort and compliance during the initiation phase.